(0.36%) 5 206.60 points
(0.65%) 39 309 points
(0.24%) 16 343 points
(0.05%) $79.03
(4.80%) $2.29
(0.77%) $2 340.20
(2.82%) $28.38
(0.80%) $992.45
(-0.25%) $0.928
(-0.26%) $10.86
(-0.15%) $0.799
(0.88%) $92.54
-1.23% INR 1 019.75
Live Chart Being Loaded With Signals
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India...
Stats | |
---|---|
Today's Volume | 57 982.00 |
Average Volume | 159 748 |
Market Cap | 49.80B |
EPS | INR0 ( 2024-05-08 ) |
Next earnings date | ( INR0 ) 2024-08-08 |
Last Dividend | INR3.00 ( 2012-09-13 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 35.81 |
ATR14 | INR1.533 (0.15%) |
Volume Correlation
Orchid Pharma Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Orchid Pharma Limited Correlation - Currency/Commodity
Orchid Pharma Limited Financials
Annual | 2022 |
Revenue: | INR6.66B |
Gross Profit: | INR2.81B (42.24 %) |
EPS: | INR11.35 |
FY | 2022 |
Revenue: | INR6.66B |
Gross Profit: | INR2.81B (42.24 %) |
EPS: | INR11.35 |
FY | 2022 |
Revenue: | INR5.60B |
Gross Profit: | INR2.33B (41.69 %) |
EPS: | INR-0.350 |
FY | 2021 |
Revenue: | INR4.50B |
Gross Profit: | INR2.10B (46.68 %) |
EPS: | INR-28.55 |
Financial Reports:
No articles found.
Orchid Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR2.67 | 2002-07-16 |
Last Dividend | INR3.00 | 2012-09-13 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | INR36.67 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.66 | -- |
Div. Sustainability Score | 4.51 | |
Div.Growth Potential Score | 2.51 | |
Div. Directional Score | 3.51 | -- |
Year | Amount | Yield |
---|---|---|
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SSWL.NS | Dividend Junior | 2023-08-14 | Annually | 20 | 0.30% | |
MRF.NS | Dividend Knight | 2023-07-20 | Semi-Annually | 23 | 0.11% | |
HGINFRA.NS | Dividend Junior | 2023-08-14 | Sporadic | 7 | 0.13% | |
BLISSGVS.NS | Dividend Junior | 2023-07-12 | Annually | 15 | 0.46% | |
RECLTD.NS | Dividend King | 2023-08-14 | Quarterly | 17 | 6.82% | |
KOVAI.NS | Dividend Junior | 2023-08-10 | Annually | 4 | 0.17% | |
EXIDEIND.NS | Dividend Junior | 2023-08-01 | Annually | 22 | 0.76% | |
AMIORG.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.15% | |
TASTYBITE.NS | Dividend Junior | 2023-07-14 | Annually | 8 | 0.01% | |
NGIL.NS | No Dividend Player | 2023-09-21 | Annually | 4 | 0.08% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.145 | 1.500 | 7.10 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.131 | 1.500 | 9.65 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.21 | 1.000 | 9.18 | 9.18 | [3 - 30] |
operatingCashFlowPerShareTTM | 12.63 | 2.00 | 5.79 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 12.63 | 2.00 | 3.69 | 7.37 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.415 | 1.000 | 6.42 | 6.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.131 | 1.000 | 9.38 | 9.38 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.51 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 44.34 | 1.000 | 5.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.131 | 2.50 | 9.78 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 12.63 | 2.00 | 5.79 | 7.37 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 12.63 | 2.00 | 5.79 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.180 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0789 | 1.000 | -0.528 | 0 | [0.1 - 0.5] |
Total Score | 2.51 |
Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators